it's kind of inevitable that myx will bottom out at some stage soon, the accounts show that the impairments have dropped approximately $500m in net profit over the last three years. Effectively since they overpaid for generics, these losses have also pushed the market cap from a $1.3 billion company to around $5-600 million. Once these impacts are washed out, and the accounts look cleaner (not in the red) with a few other cash generating drugs in the line then a correction to moving upwards in share price to a market cap of around 7-800mill
it's kind of inevitable that myx will bottom out at some...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.93 |
Change
-0.170(2.39%) |
Mkt cap ! $589.5M | |||
| Open | High | Low | Value | Volume |
| $6.96 | $7.10 | $6.92 | $445.2K | 63.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2808 | $6.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.96 | 1106 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.91 |
Change
-0.170 ( 2.37 %) |
||||
| Open | High | Low | Volume | ||
| $7.05 | $7.06 | $6.91 | 8328 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| MYX (ASX) Chart |